Market Place
Sourcing Support
Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India
09 Oct 2024 //
PRESS RELEASE
Dr. Reddy`s, Aurigene, And Kainomyx Announce Potential Malaria Drug Partnership
20 Aug 2024 //
PRESS RELEASE
Aurigene to Provide Cell Therapy Discovery Services
01 Jul 2024 //
PRESS RELEASE
Aurigene Opens Biologics Facility For Process, Clinical Manufacturing
03 Jun 2024 //
PRESS RELEASE
Aurigene & Vipergen Partner to Co-Market & Offer DEL Screening to Customers
19 Apr 2024 //
PRESS RELEASE
Dr Reddy`s arm rolls AI&ML assisted drug discovery platform Aurigene.AI
04 Apr 2024 //
PRESS RELEASE
Aurigene introduces Aurigene.AI & ML assisted drug discovery platform
03 Apr 2024 //
BUSINESSWIRE
Aurigene Pharmaceutical Services to set up USD 40 mn facility in Hyderabad
04 Jul 2023 //
HEALTH ET
Aurigene Pharmaceutical Services to expand biologics CDMO capacity with a new biomanufacturing facility
22 May 2023 //
PRESS RELEASE
Dr. Reddy`s subsidiary hits the pause button on drug development for psoriasis
16 Dec 2022 //
ENDPTS
Dr. Reddy’s to explore opportunities for developing new drugs for NTDs
30 Aug 2022 //
PRESS RELEASE
Dr Reddy`s arm inks pact with US-based Olema Pharmaceuticals
10 Jun 2022 //
ECONOMIC TIMES
Aurigene Pharmaceutical Services,Launches its New Branding at CPhI North America
15 May 2022 //
PRESS RELEASE
Akhil Ravi Appointed CEO of Aurigene Pharmaceutical Services Ltd
04 Feb 2022 //
PHARMACYTIMES
FBL gives Aurigene Pharma license to manufacture Molnupiravir via enzymatic tech
21 Jan 2022 //
LIVEMINT
Fermenta Bio licenses its technology for manufacturing molnupiravir to Aurigene
21 Jan 2022 //
PHARMABIZ
Aurigene Pharma (APSL) invests in adding Large Molecule D&D Services
11 Nov 2021 //
PRESS RELEASE
DeepMatter to trial its DigitalGlassware® platform with Aurigene Pharmaceutical
21 Oct 2021 //
PRESS RELEASE
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Gov.PENAO
09 Sep 2021 //
YAHOO
Beroni Begins Manufacture of Anti-Cancer Drug PENAO
19 Aug 2021 //
PRESS RELEASE
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
18 Aug 2021 //
GLOBENEWSWIRE
Oligonucleotide as a novel class of therapeutic modality
02 Jul 2021 //
PRESS RELEASE
Emerging Trends in Solid Phase Peptide Synthesis
23 Feb 2021 //
PRESS RELEASE
Introduction to PROTAC
08 Feb 2021 //
PRESS RELEASE
Advantages of PROTACs over traditional drugs
08 Feb 2021 //
PRESS RELEASE
Importance of Route Scouting in Chemical Development
05 Feb 2021 //
PRESS RELEASE
Role of Peptide Synthesis Based Drugs
04 Jan 2021 //
PRESS RELEASE
The Role of DMPK Studies in Drug Discovery
04 Jan 2021 //
PRESS RELEASE
Application of mPEGs in Drug Discovery and Development
04 Jan 2021 //
PRESS RELEASE
The Importance of Carbohydrate Synthesized Drugs
04 Jan 2021 //
PRESS RELEASE
Application & Manufacturing of High Potent Active Pharmaceutical (HPAPI)
04 Jan 2021 //
PRESS RELEASE
The influence of formulation development and its route of administration
04 Jan 2021 //
PRESS RELEASE
